Literature DB >> 6289663

Angiotensin-converting enzyme in diseases of the liver.

K Matsuki, T Sakata.   

Abstract

Serum angiotensin-converting enzyme activity was measured in various diseases of the liver. Activity increased in progressive order in patients with chronic persistent hepatitis, chronic aggressive hepatitis, and liver cirrhosis. Activity was increased also in patients with acute hepatitis. On the other hand, patients with fatty liver had normal angiotensin-converting enzyme activity and patients with extrahepatic obstructive jaundice showed subnormal activity. Although the mechanism for these enzymatic changes in diseases of the liver remains to be elucidated, serum angiotensin-converting enzyme determination may be useful in the diagnosis of diseases of the liver under certain conditions.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6289663     DOI： 10.1016/0002-9343(82)90335-7

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


  7 in total

1.  Direct radioimmunoassay of angiotensin-converting enzyme in sera from patients with pulmonary diseases.

Authors:  K Hiwada; Y Inoue; Y Takada; A Hashimoto; H Akutsu; F Kitatani; T Kokubu
Journal:  Lung       Date:  1987       Impact factor: 2.584

2.  Changes in indocyanine green kinetics after the administration of enalapril to healthy subjects.

Authors:  J Geneve; T Le Dinh; A Brouard; M Bails; J M Segrestaa; C Caulin
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

3.  Increased angiotensin-converting enzyme activities in diabetes mellitus: analysis of diabetes type, state of metabolic control and occurrence of diabetic vascular disease.

Authors:  G Schernthaner; C Schwarzer; R Kuzmits; M M Müller; U Klemen; H Freyler
Journal:  J Clin Pathol       Date:  1984-03       Impact factor: 3.411

4.  Serum angiotensin converting enzyme in Sjogren's syndrome--a case report and study of 21 further cases.

Authors:  N D Machin; M D Chard; E W Paice
Journal:  Postgrad Med J       Date:  1984-04       Impact factor: 2.401

5.  Systemic administration of platelet-activating factor in rat reduces specific pulmonary uptake of circulating monoclonal antibody to angiotensin-converting enzyme.

Authors:  E N Atochina; H H Hiemisch; V R Muzykantov; S M Danilov
Journal:  Lung       Date:  1992       Impact factor: 2.584

6.  Response of serum angiotensin converting enzyme, plasma renin activity and plasma aldosterone to conventional dialysis in patients on chronic haemodialysis.

Authors:  C Letizia; S Mazzaferro; S Morabito; A De Ciocchis; S Cerci; C D'Ambrosio; G A Cinotti; D Scavo
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

7.  Changes of serum angiotensin-converting enzyme activity during treatment of patients with Graves' disease.

Authors:  D S Lee; J K Chung; B Y Cho; C S Koh; M Lee
Journal:  Korean J Intern Med       Date:  1986-01       Impact factor: 2.884
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.